Responding to Market Failures in Tuberculosis Control

• Published in: Science (American Association for the Advancement of Science) Vol. 293; no. 5532; pp. 1049 - 1051
• Main Authors: Gupta, Rajesh, Kim, Jim Y., Espinal, Marcos A., Caudron, Jean-Michel, Pecoul, Bernard, Farmer, Paul E., Raviglione, Mario C.
• Format: Journal Article
• Language: English
• Published: Washington American Society for the Advancement of Science 10-08-2001; American Association for the Advancement of Science; The American Association for the Advancement of Science
• Subjects: Agricultural management; Antibiotics; Antituberculars; Average prices; Company business management; Cost control; Developing countries; Disease control; Drug costs; Drug resistance; Drug resistance in microorganisms; Drug therapy; Expenditures; Infectious diseases; International aspects; LDCs; Management; Market prices; Microbial drug resistance; Mycobacterium tuberculosis; Narcotics; Patients; Pilot Projects; Policy Forum; Prevention; Public Health; Social aspects; Tuberculosis; Tuberculosis control; World health
• ISSN: 0036-8075; 1095-9203
• DOI: 10.1126/science.1061861

The World Health Organization established a Working Group for the DOTS-PLUS approach, which is still under development, but which aims to manage multidrug-resistant tuberculosis (MDR-TB) using second-line drugs in low- and middle-income countries. The Working Group emphasizes the need for DOTS-Plus projects to be underpinned by functioning national TB programs that promote sound TB control practices for all patients.